Brief: Regenxbio Q4 License & Royalty Revenue USD 21.214 Million
13/03/2025 21:37
March 13 (Reuters) - Regenxbio Inc RGNX.O: REGENXBIO Q4 LICENSE & ROYALTY REVENUE USD 21.214 MILLION REGENXBIO Q4 NET INCOME USD -51.186 MILLION REGENXBIO Q4 PRETAX PROFIT USD -51.186 MILLION REGENXBIO Q4 OPERATING EXPENSES USD 72.582 MILLION Source text: ID:nPnZDYwHa Further company coverage: RGNX.O ((Reuters.Briefs@thomsonreuters.com;))